Avalo Therapeutics Inc (AVTX) Live Share Price, Invest From India

Avalo Therapeutics Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

Day's Low
Day's High
$12.96
Day's Price Range
$14.02
$13.67
5.19%
Downside
2.56%
Upside
52 Week's Low
52 Week's High
$3.39
52-Week Price Range
$20.72
$13.67
75.20%
Downside
51.57%
Upside

Avalo Therapeutics Inc share price movements today

Previous Close: $13.40
Open: $13.53
Volume: 1.0M
Day's Low - High: $12.96 - $14.02
52 Week Low - High: $3.39 - $20.72

Avalo Therapeutics Inc Historical Returns

1 Month Return: -22.8 %
3 Month Return: -12.4 %
1 Year Return: + 172.02 %
3 Year Return: -98.16 %
5 Year Return: 0 %

Avalo Therapeutics Inc Stock Fundamentals & Key Indicators

Check Avalo Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$305.4M

EPS (TTM)

-3.2367

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-72.6M

Revenue (TTM)

59.0K

Profit Margin

0.00%

Return On Equity TTM

-72.44%

Avalo Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Avalo Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Avalo Therapeutics Inc	SELL	$305.4M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Stock Returns calculator for Avalo Therapeutics Inc Stock including INR - Dollar returns

The Avalo Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Avalo Therapeutics Inc investment value today

Current value as on today

₹3,04,549

Returns

₹2,04,549

(+204.55%)

Returns from Avalo Therapeutics Inc Stock

₹1,71,230 (+171.23%)

Dollar Impact

₹33,319 (+33.32%)

Analyst Recommendation on Avalo Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Avalo Therapeutics Inc. Average target price of $40.09

Avalo Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Avalo Therapeutics Inc.

What analysts predicted

65.9%UPSIDE

Target Price

$40.09

Current Price

$13.67

Analyzed by

6 Analysts

Target

$40.09

Avalo Therapeutics Inc target price $40.09, a slight upside of 65.9% compared to current price of $13.67. According to 6 analysts rating.

Avalo Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Avalo Therapeutics Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 3, 2026 to May 3, 2026

Change:-31% versus previous 30 day period

Avalo Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	-	-	0	0	-	-	-	0
Gross Profit	0	0	0	0	0	0	-	0	-	0
Operating Income	-3	-3	-5	-9	-12	-13	-14	-19	-19	-19
EBITDA	-3	-8	-5	-9	-12	-13	-14	-19	-30	-19
Interest Expense	1	0	-	1	0	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-8	-121	98	23	-35	-13	-20	-30	-13
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-5	-8	-121	98	23	-35	-13	-20	-30	-13
Net Profit Margin	-2215.25%	-1430.47%	0.00%	0.00%	9251.81%	-18405.73%	0.00%	0.00%	0.00%	-23254.24%

Avalo Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	27	18	6	6	5	18	1	0	0
Gross Profit	-7	27	10	7	6	3	14	0	0	0
Operating Income	-16	13	-39	-16	-26	-82	-37	-27	-68	-72
EBITDA	-16	14	-13	-13	-45	-80	-37	-23	-68	-72
Interest Expense	0	0	0	2	39	2	4	3	3	-
Depreciation	-	0	4	3	1	1	0	0	0	0
Income Before Tax	-16	13	-40	-15	-67	-84	-41	-31	-35	-78
Income Tax Expense	0	1	0	0	-2	0	0	0	0	0
Net Income	-16	11	-40	-16	-63	-84	-41	-31	-35	-78
Net Profit Margin	-1428.53%	42.68%	-218.55%	-238.10%	-947.90%	-1563.10%	-230.78%	-1639.50%	-7965.76%	-132642.37%

Avalo Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-8	-121	98	23	-35	-13	-20	-30	-13
Operating Cash Flow	-2	-6	-16	-11	-15	-9	-11	-16	-14
Investing Cash Flow	0	0	0	-	-	-	-70	-13	2
Financing Cash Flow	0	108	0	-	67	-	0	14	0
Change in Cash	-2	102	-16	-11	52	-9	-82	-15	-11

Avalo Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	11	-40	-16	-63	-84	-41	-31	-35	-78
Operating Cash Flow	12	-3	-19	-40	-70	-26	-30	-49	-51
Investing Cash Flow	-18	0	0	11	0	0	0	0	-81
Financing Cash Flow	3	10	12	44	106	-14	25	175	14
Change in Cash	-2	8	-7	15	35	-41	-5	127	-118

Global Institutional Holdings in Avalo Therapeutics Inc

Funds	Holdings
Perceptive Advisors LLC	1.06%
RA Capital Management, LLC	2.71%
Ikarian Capital, LLC	0.27%
Affinity Asset Advisors, LLC	5.44%
Point72 Asset Management, L.P.	5.69%

See all

Insights on Avalo Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -30.62M → -13.72M (in $), with an average increase of 123.2% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, AVTX has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Avalo Therapeutics Inc has experienced a drawdown of -98.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 85.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, AVTX stock has moved down by -22.8%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 571.0K → 59.0K (in $), with an average decrease of 49.5% per quarter

About Avalo Therapeutics Inc

Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.

Organisation	Avalo Therapeutics Inc
Headquarters	1500 Liberty Ridge Drive, Wayne, PA, United States, 19087
Industry	Biotechnology
CEO	Dr. Garry A. Neil M.D.
E-voting on shares	Click here to vote

Key Management of Avalo Therapeutics Inc

Name	Title
Mr. Paul C. Varki J.D., M.P.H	Chief Legal Officer
Ms. Ashley Ivanowicz	Senior Vice President of Human Resources
Dr. Garry A. Neil M.D.	President, CEO & Director
Dr. Mittie Doyle FACR, M.D.	Chief Medical Officer
Mr. Christopher Ryan Sullivan CPA	CFO & Head of Investor relations
Dr. Dino C. Miano Ph.D.	Senior Vice President of CMC & Technical Operations
Ms. Jennifer Riley	Chief Strategy Officer
Mr. Taylor Boyd	Chief Business Officer
Dr. Solomon H. Snyder M.D.	Founder and Chairman of Scientific Advisory Board
Dr. Barbara S. Slusher Ph.D.	Founder and Member of Scientific Advisory Board

FAQs

What is Avalo Therapeutics Inc share price today?

Avalo Therapeutics Inc share price today is $13.67 as on May 2, 2026 at 1:29 am IST at the close of the market. Avalo Therapeutics Inc share today touched a day high of $14.02 and a low of $12.96.

What is the 52 week high and 52 week low for Avalo Therapeutics Inc share?

Avalo Therapeutics Inc share touched a 52 week high of $20.72 on December 11, 2025 and a 52 week low of $3.39 on May 14, 2025. Avalo Therapeutics Inc stock price today i.e. May 2, 2026 at 1:29 am IST is closed at $13.67,which is 34.02% down from its 52 week high and 303.24% up from its 52 week low.

What is Avalo Therapeutics Inc's market capitalisation today?

Avalo Therapeutics Inc market capitalisation is $0.00T as on May 2, 2026 at 1:29 am IST.

How to invest in Avalo Therapeutics Inc Stock (AVTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Avalo Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avalo Therapeutics Inc Shares that will get you 0.1097 shares as per Avalo Therapeutics Inc share price of $13.67 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Avalo Therapeutics Inc Stock (AVTX) from India?

Indian investors can start investing in Avalo Therapeutics Inc (AVTX) shares with as little as ₹94.91 or $1 (as of May 3, 2026 at 8:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Avalo Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 3, 2026 at 8:38 am IST). Based on Avalo Therapeutics Inc share’s latest price of $13.67 as on May 2, 2026 at 1:29 am IST, you will get 0.7315 shares of Avalo Therapeutics Inc. Learn more about fractional shares .